Sera Prognostics (SERA) Short term Debt (2020)

Sera Prognostics (SERA) posted Short term Debt of $4.4 million for Q4 2020.

Sera Prognostics (SERA) Short term Debt (2020) Analysis & Trends

Sera Prognostics' Short term Debt history runs 1 years deep, the most recent figure standing at $4.4 million for Q4 2020.

  • Quarterly Short term Debt changed N/A year-over-year to $4.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $4.4 million (changed N/A YoY) and the FY2020 annual result came in at $4.4 million, changed N/A from the prior year.
  • Short term Debt was $4.4 million for Q4 2020 at Sera Prognostics.
  • Across five years, Short term Debt topped out at $4.4 million in Q4 2020 and bottomed at $4.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.13 Bn 175.84 Bn 6.27 Bn
2 Stryker 128.86 Bn 125.99 Bn 3.81 Bn
3 Medtronic 108.95 Bn 99.73 Bn 6.41 Bn
4 Boston Scientific 68.42 Bn 66.97 Bn 3.61 Bn
5 Edwards Lifesciences 48.30 Bn 44.63 Bn 1.29 Bn
6 GE HealthCare Technologies 28.33 Bn 26.04 Bn 1.98 Bn
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn
8 Smith & Nephew 26.89 Bn 26.31 Bn -
9 Koninklijke Philips 25.43 Bn 22.30 Bn 2.07 Bn
10 Sera Prognostics 102.28 Mn 102.28 Mn -28,000.00

Historic Data

Download Data
DateValue
Dec 31, 2020 4.35 Mn